Geraldine A. Henwood

Recro Pharma Inc (NASDAQ: REPH) is a micro-cap specialty pharmaceutical company focused on the development of non-opioid products for the treatment of serious acute pain. After a very volatile year, the stock is down 9.4 percent, although it has gained almost 14.5 percent in the last month, largely...